Group One Trading’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-27,996
Closed -$41.6K 8097
2022
Q4
$40K Sell
27,996
-23,598
-46% -$46K ﹤0.01% 5165
2022
Q3
$115K Buy
+51,594
New +$125K ﹤0.01% 4655
2021
Q4
Sell
-248,280
Closed -$847K 8960
2021
Q3
$879K Sell
248,280
-42,075
-14% -$140K ﹤0.01% 3558
2021
Q2
$920K Buy
290,355
+51,087
+21% +$161K ﹤0.01% 3517
2021
Q1
$823K Buy
239,268
+99,143
+71% +$308K ﹤0.01% 3460
2020
Q4
$353K Buy
140,125
+119,899
+593% +$261K ﹤0.01% 3584
2020
Q3
$43K Buy
20,226
+15,099
+294% +$35.9K ﹤0.01% 4737
2020
Q2
$11K Buy
+5,127
New +$13.2K ﹤0.01% 5094
2018
Q1
Sell
-7,198
Closed -$50.7K 5388
2017
Q4
$59K Sell
7,198
-13,800
-66% -$132K ﹤0.01% 3641
2017
Q3
$220K Buy
+20,998
New +$233K ﹤0.01% 2701
2017
Q2
Sell
-3,318
Closed -$30.9K 5173
2017
Q1
$28K Buy
3,318
+2,800
+541% +$19.7K ﹤0.01% 3727
2016
Q4
$4K Buy
+518
New +$3.31K ﹤0.01% 4158
2016
Q2
Sell
-5,798
Closed -$32.2K 5003
2016
Q1
$26K Hold
5,798
﹤0.01% 3620
2015
Q4
$26K Buy
5,798
+1,940
+50% +$8.19K ﹤0.01% 3784
2015
Q3
$12K Buy
+3,858
New +$11.7K ﹤0.01% 4240
2015
Q1
Sell
-158
Closed -$517 5283
2014
Q4
$1K Buy
+158
New +$753 ﹤0.01% 4789
2014
Q2
Sell
-18,245
Closed -$78.9K 5555
2014
Q1
$76K Buy
18,245
+4,900
+37% +$16.8K ﹤0.01% 3305
2013
Q4
$39K Buy
13,345
+6,200
+87% +$15.4K ﹤0.01% 3816
2013
Q3
$18K Buy
+7,145
New +$16.9K ﹤0.01% 4234

Other funds holding ENZ

Group One Trading's ENZ Position: Q1 2023 in Review

Group One Trading sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 27,996 shares — an estimated $41.6K sold.

Group One Trading first reported a position in ENZ in Q3 2013 and held it in 19 quarters. The position peaked at $920K in Q2 2021. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.

  • Group One Trading reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 27,996 Enzo Biochem, Inc. shares in Q1 2023, an estimated $41.6K.
  • Group One Trading first reported a position in Enzo Biochem, Inc. in Q3 2013 and held it in 19 quarters.
  • Group One Trading's Enzo Biochem, Inc. position peaked at $920K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.